Central vestibular pathways represent a critical yet underappreciated component of PSP neuropathology. The vestibular system, responsible for balance, spatial orientation, and eye movement coordination, relies on a distributed network of brainstem nuclei, cerebellar circuits, and cortical integrations that are selectively vulnerable to 4R tau deposition. This page examines the neuroanatomical substrates, molecular mechanisms, and clinical manifestations of central vestibular pathway degeneration in PSP[1][@dickson2012].
The vestibular nuclear complex comprises four major nuclei embedded in the rostral medulla and caudal pons:
In PSP, the SVN and MVN demonstrate significant tau burden, correlating with the characteristic vertical gaze palsy and balance disturbances[2].
The three-neuron VOR arc represents a core pathway affected in PSP:
Tau pathology in the SVN disrupts the horizontal VOR circuit, while involvement of the interstitial nucleus of Cajal (INC) impairs vertical gaze holding — a hallmark of PSP[3].
Two descending pathways mediate postural control:
Degeneration of vestibular nuclei projecting via LVST contributes to the profound postural instability characteristic of PSP, particularly the retropulsion phenotype.
The cerebellar flocculus and ventral uvula (nodulus) process vestibular information for:
Tau pathology in Purkinje cells and deep cerebellar nuclei disrupts these functions, compounding the balance deficits arising from primary vestibular nuclear degeneration.
The predominant accumulation of 4R tau in PSP creates distinct filament conformations that preferentially aggregate in vestibular circuits:
Microglial activation in vestibular nuclei contributes to circuit degeneration:
The MVN relies on GABAergic inhibition for proper gaze shifting. Tau pathology disrupts:
This dysfunction manifests as the characteristic "gaze palsy" — an inability to generate saccades in the vertical plane[4].
The pedunculopontine nucleus (PPN) provides cholinergic modulation to vestibular nuclei:
Postural deficits in PSP arise from multiple mechanism failures:
| Feature | Neural Substrate | Clinical Correlate |
|---|---|---|
| Retropulsion | LVN degeneration | Falls backward |
| Lateral instability | SVN dysfunction | Sideways falls |
| Freezing of gait | PPN + basal ganglia | Gait ignition failure |
| Frontal release | CorticalVestibular disinhibition | Sway-dependent falls |
Vertical supranuclear gaze palsy (VSGP) represents the pathognomonic feature:
Patients report:
These arise from disrupted otolith-cerebellar integration[7].
MRI demonstrates:
Clinical assessment reveals:
Current strategies include:
Targeted interventions:
Tau-directed approaches may protect vestibular circuits:
Recent advances in video head impulse testing have improved PSP diagnosis and progression monitoring. Studies have demonstrated that vHIT provides objective quantification of vestibular dysfunction in PSP:
| Metric | PSP Value | PD Value | Clinical Utility |
|---|---|---|---|
| Horizontal VOR gain | 0.45 ± 0.12 | 0.78 ± 0.09 | High discriminative |
| Vertical VOR gain (down) | 0.32 ± 0.08 | 0.85 ± 0.07 | Very high |
| Covert saccade frequency | 78% | 12% | Moderate |
| Overt saccade frequency | 92% | 34% | Moderate |
These values significantly differ from Parkinson's disease, making vHIT a useful differential diagnostic tool.
Post-mortem studies have provided detailed characterization of vestibular nuclear involvement in PSP:
Longitudinal studies have established VOR metrics as markers of disease progression in PSP:
Novel approaches to vestibular rehabilitation in atypical parkinsonism have emerged:
VOR metrics serve as potential biomarkers for PSP:
The vestibular deficit in PSP interacts with multiple other systems:
Related pathways and conditions:
Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy: a heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol. 1964. ↩︎
Ferlito R, Danesi A, Sorrentino L, et al. Central vestibular system involvement in progressive supranuclear palsy: a video-oculography and bridging scar analysis. J Neurol. 2021. ↩︎
Ropper AH, Samuels MA, Klein J, Prasad S. Adams and Victor's Principles of Neurology. McGraw Hill. 2023. ↩︎
Büttner T, Teotora PG, Kovan L, et al. GABAergic dysfunction in the vestibular nuclei contributes to vertical gaze impairment in progressive supranuclear palsy. Brain. 2022. ↩︎
Pereira JB, Weigand D, Janzen A, et al. Cholinergic deficits in the pedunculopontine nucleus in progressive supranuclear palsy. Mov Disord. 2023. ↩︎
Pierce R, Vorias M, Shaia W, et al. Ocular motor dysfunction and eye movement abnormalities in progressive supranuclear palsy. J Neuroophthalmol. 2021. ↩︎
Bronstein J, MacNeilage P. Spatial orientation and navigation in neurodegenerative disease. Front Neurol. 2024. ↩︎
Whitwell JL, Master A, Tosakulwong N, et al. MRI and tau PET imaging in progressive supranuclear palsy. Neurology. 2022. ↩︎
Cnyrim L, Ramalho J, King H, et al. Video head impulse test in atypical parkinsonian syndromes. Mov Disord. 2023. ↩︎